Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood

Keyphrases

• Leukocytes 100%
• Heterochromatin 100%
• Epigenetics 100%
• Human Blood 100%
• Heterochromatin Proteins 100%
• Leukemia Cells 100%
• Terminally Differentiated 100%
• Cell Differentiation 80%
• Monocytes 60%
• Leukemia Patients 40%
• Chromatin Condensation 40%
• Chronic Myeloid Leukemia 40%
• Terminal Cells 40%
• Nuclear Chromatin 40%
• Immunoblotting 20%
• Myeloid Cells 20%
• Lysine 20%
• Cell-derived 20%
• Retinoic Acid 20%
• Acute Myeloid Leukemia 20%
• Expression Level 20%
• Leukemia 20%
• Peripheral Blood Leukocytes 20%
• Isolated Cells 20%
• Normal Blood 20%
• Cell nucleus 20%
• Histone H3 20%
• Degree of Differentiation 20%
• Immunofluorescence 20%
• Nucleoplasm 20%
• Hematological Malignancies 20%
• Chromatin Factor 20%
• Blood Cells 20%
• U937 Cells 20%
• Blast Crisis 20%
• Terminally Differentiated Cells 20%
• Serpin 20%
• Peripheral Blood Cells 20%
• Accelerated Phase 20%
• Blood Cell Populations 20%
• Leukemia Therapy 20%
• Leukemia Progression 20%

Biochemistry, Genetics and Molecular Biology

• Leukocyte 100%
• Heterochromatin 100%
• Cellular Differentiation 80%
• Myeloid 60%
• Heterochromatin Protein 1 60%
• Neutrophil Elastase 60%
• Monocyte 60%
• Chromatin Condensation 40%
• Immunofluorescence 20%
• Hemocyte 20%
• Histone H3 20%
• Tretinoin 20%
• Retinoic Acid 20%
• Serpin 20%
• Chromatin 20%
• Peripheral Blood Cell 20%
• Lysine 20%
• Immunoblotting 20%
• Expression Level 20%